Drug recall D-1289-2014
Product
LUPRON DEPOT-PED (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 11.25 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3779-03, UPC 3 00743 77903 5.
Reason for recall
Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.
Lots and codes
Lot #:1013566, Exp 12/08/16
Recall details
- Recalling firm
- AbbVie Inc, North Chicago, IL
- Quantity
- 12 kits
- Distribution
- Nationwide and Puerto Rico
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 10, 2014
- Terminated
- June 22, 2016
Related products
- Lupron Depot-PED – drug information
- NDC 0074-2108 Lupron Depot-PED · · AbbVie Inc.
- NDC 0074-2440 Lupron Depot-PED · · AbbVie Inc.
- NDC 0074-3779 Lupron Depot-PED · · AbbVie Inc.
- NDC 0074-3575 Lupron Depot-PED · · AbbVie Inc.
- NDC 0074-9694 Lupron Depot-PED · · AbbVie Inc.
- NDC 0074-2282 Lupron Depot-PED · · AbbVie Inc.